Puncher for cell line Development (Q3989339)
Jump to navigation
Jump to search
Project Q3989339 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Puncher for cell line Development |
Project Q3989339 in Netherlands |
Statements
283,786.04 Euro
0 references
1,542,992.97 Euro
0 references
18.392 percent
0 references
11 May 2020
0 references
30 June 2023
0 references
JB Ventures
0 references
Kane Tronics
0 references
Stevens Ide partners
0 references
Universiteit Twente
0 references
VyCAP
0 references
52°21'31.14"N, 6°30'15.73"E
0 references
7442CL
0 references
In dit project zal een Puncher platform demonstrator worden gerealiseerd en gevalideerd om hiermee antilichaam producerende monoclonale cellijnen sneller en kosten effectiever te ontwikkelen. Antilichamen worden gebruikt bij de behandeling van kan... (Dutch)
0 references
In this project, a Puncher platform demonstrator will be realised and validated to develop antibody-producing monoclonal cell lines more quickly and cost effectively. Antibodies are used in the treatment of... (English)
15 December 2021
0 references
Dans le cadre de ce projet, un démonstrateur de plateforme Puncher sera réalisé et validé afin de développer des lignées cellulaires monoclonales produisant des anticorps plus rapidement et plus efficacement. Les anticorps sont utilisés dans le traitement de... (French)
15 December 2021
0 references
In diesem Projekt wird ein Puncher-Plattform-Demonstrator realisiert und validiert, um antikörperproduzierende monoklonale Zelllinien schneller und kostengünstiger zu entwickeln. Antikörper werden bei der Behandlung von... (German)
15 December 2021
0 references
In questo progetto, un dimostratore di piattaforma Puncher sarà realizzato e convalidato per sviluppare linee cellulari monoclonali che producono anticorpi in modo più rapido ed economico. Gli anticorpi sono utilizzati nel trattamento di... (Italian)
11 January 2022
0 references
En este proyecto, se realizará y validará un demostrador de plataforma Puncher para desarrollar líneas celulares monoclonales productoras de anticuerpos de forma más rápida y rentable. Los anticuerpos se utilizan en el tratamiento de... (Spanish)
12 January 2022
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00971
0 references